Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
BioLargo, Inc. (BLGO) had Return on Equity of -37.74% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$3.27M |
|
$-1.16M |
|
$1.78M |
|
$1.49M |
|
$5.13M |
|
$-1.86M |
|
$-0.06M |
|
$-1.92M |
|
$-1.92M |
|
$-1.92M |
|
$-1.92M |
|
$-1.92M |
|
$-1.92M |
|
$-1.86M |
|
$-1.76M |
|
301.27M |
|
301.27M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$7.22M |
|
$1.70M |
|
$3.29M |
|
$10.51M |
|
$3.37M |
|
$1.15M |
|
$2.05M |
|
$5.42M |
|
$5.09M |
|
$5.09M |
|
$5.09M |
|
301.76M |
|
| Cash Flow Statement Financials | |
$-1.83M |
|
-- |
|
$0.87M |
|
$3.55M |
|
$2.56M |
|
$-0.98M |
|
$0.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.14 |
|
-- |
|
-- |
|
0.18 |
|
0.40 |
|
45.52% |
|
-56.96% |
|
-56.96% |
|
-- |
|
-58.76% |
|
-35.33% |
|
$-1.83M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
4.83 |
|
0.78 |
|
115.85 |
|
|
Return on Equity |
-37.74% |
-37.74% |
|
-18.28% |
|
-30.78% |
|
$0.02 |
|
$-0.01 |
|
$-0.01 |
|